Orthomyxoviridae Infections [clinicaltrials_resource:9da3f383276de9a4153d3938b5fd99b5]
Immunogenicity Study of the Influenza Vaccine in Adults [clinicaltrials:NCT00258934]A Study of the Immunogenicity and Safety of the 2006-2007 Influenza Vaccine [clinicaltrials:NCT00343681]Safety and Immunogenicity of an Intramuscular Pandemic Influenza Vaccine in Adults and the Elderly [clinicaltrials:NCT00415129]Safety and Immunogenicity of H5N1 Adjuvanted, Inactivated, Split-Virion Pandemic Influenza Vaccine in Healthy Adults [clinicaltrials:NCT00457509]A Study of the Immunogenicity and Safety of the 2007-2008 Influenza Vaccine [clinicaltrials:NCT00491257]Safety and Immunogenicity of 2 Formulations of an Intramuscular A/H5N1 Pandemic Influenza Vaccine in Children [clinicaltrials:NCT00491985]Immunogenicity and Safety of an Intramuscular A/H5N1 Inactivated, Split Virion Pandemic Influenza Vaccine in Adults [clinicaltrials:NCT00545701]Immunogenicity of the Inactivated Split-Virion Influenza Vaccine in Renal Transplant Subjects [clinicaltrials:NCT00606359]Study of Different Formulations of an Intramuscular A/H5N1 Inactivated, Split Virion Influenza Adjuvanted Vaccine [clinicaltrials:NCT00664417]Immunogenicity and Safety of the Inactivated, Split-Virion Influenza Vaccine, Northern Hemisphere 2008-2009 Formulation [clinicaltrials:NCT00718146]clinicaltrials:NCT00755274Safety and Immunogenicity of an Intramuscular A/H5N1 Inactivated, Split Virion Pandemic Influenza Vaccine in Children [clinicaltrials:NCT00884182]Novel Influenza A/H1N1 Split- Virion Vaccine in Healthy Population Aged 3 Years and Older [clinicaltrials:NCT00975572]clinicaltrials:NCT01055990DNA-based Influenza Vaccine in the Elderly [clinicaltrials:NCT01587131]Safety of H1N1 Influenza Vaccination in Pregnant Women [clinicaltrials:NCT01842997]
condition [clinicaltrials_vocabulary:condition]
Immunogenicity Study of the Influenza Vaccine in Adults [clinicaltrials:NCT00258934]Immunogenicity of Two Dosages of Inactivated, Split-Virion Influenza Vaccine Given by an Alternate Route in the Elderly [clinicaltrials:NCT00296829]A Study of the Immunogenicity and Safety of the 2006-2007 Influenza Vaccine [clinicaltrials:NCT00343681]Study of Inactivated, Split-Virion Influenza Vaccine Compared With the Reference Vaccine Vaxigrip® in the Elderly [clinicaltrials:NCT00383526]Lot-to-Lot Consistency Study of the Investigational, Inactivated, Split-Virion Influenza Vaccine in Adults [clinicaltrials:NCT00383539]clinicaltrials:NCT00388583clinicaltrials:NCT00391053clinicaltrials:NCT00391391Safety and Immunogenicity of an Intramuscular Pandemic Influenza Vaccine in Adults and the Elderly [clinicaltrials:NCT00415129]Safety and Immunogenicity of H5N1 Adjuvanted, Inactivated, Split-Virion Pandemic Influenza Vaccine in Healthy Adults [clinicaltrials:NCT00457509]A Study of the Immunogenicity and Safety of the 2007-2008 Influenza Vaccine [clinicaltrials:NCT00491257]Safety and Immunogenicity of 2 Formulations of an Intramuscular A/H5N1 Pandemic Influenza Vaccine in Children [clinicaltrials:NCT00491985]Immunogenicity and Safety of an Intramuscular A/H5N1 Inactivated, Split Virion Pandemic Influenza Vaccine in Adults [clinicaltrials:NCT00545701]Immunogenicity of the Inactivated Split-Virion Influenza Vaccine in Renal Transplant Subjects [clinicaltrials:NCT00606359]Study of Different Formulations of an Intramuscular A/H5N1 Inactivated, Split Virion Influenza Adjuvanted Vaccine [clinicaltrials:NCT00664417]Study of Inactivated, Split-Virion Influenza Vaccine Administered by Intradermal Route Versus Vaxigrip® in Adults [clinicaltrials:NCT00703651]Immunogenicity and Safety of the Inactivated, Split-Virion Influenza Vaccine, Northern Hemisphere 2008-2009 Formulation [clinicaltrials:NCT00718146]clinicaltrials:NCT00755274clinicaltrials:NCT00772109clinicaltrials:NCT00775450Study of Immune Response in Adults and Elderly Subjects Vaccinated With Inactivated Influenza Vaccines [clinicaltrials:NCT00776438]Safety and Immunogenicity of an Intramuscular A/H5N1 Inactivated, Split Virion Pandemic Influenza Vaccine in Children [clinicaltrials:NCT00884182]Novel Influenza A/H1N1 Split- Virion Vaccine in Healthy Population Aged 3 Years and Older [clinicaltrials:NCT00975572]clinicaltrials:NCT01055990DNA-based Influenza Vaccine in the Elderly [clinicaltrials:NCT01587131]Safety of H1N1 Influenza Vaccination in Pregnant Women [clinicaltrials:NCT01842997]
condition browse [clinicaltrials_vocabulary:condition-browse]
Immunogenicity Study of the Influenza Vaccine in Adults [clinicaltrials:NCT00258934]Immunogenicity of Two Dosages of Inactivated, Split-Virion Influenza Vaccine Given by an Alternate Route in the Elderly [clinicaltrials:NCT00296829]A Study of the Immunogenicity and Safety of the 2006-2007 Influenza Vaccine [clinicaltrials:NCT00343681]Study of Inactivated, Split-Virion Influenza Vaccine Compared With the Reference Vaccine Vaxigrip® in the Elderly [clinicaltrials:NCT00383526]Lot-to-Lot Consistency Study of the Investigational, Inactivated, Split-Virion Influenza Vaccine in Adults [clinicaltrials:NCT00383539]clinicaltrials:NCT00388583clinicaltrials:NCT00391053clinicaltrials:NCT00391391Safety and Immunogenicity of an Intramuscular Pandemic Influenza Vaccine in Adults and the Elderly [clinicaltrials:NCT00415129]Safety and Immunogenicity of H5N1 Adjuvanted, Inactivated, Split-Virion Pandemic Influenza Vaccine in Healthy Adults [clinicaltrials:NCT00457509]A Study of the Immunogenicity and Safety of the 2007-2008 Influenza Vaccine [clinicaltrials:NCT00491257]Safety and Immunogenicity of 2 Formulations of an Intramuscular A/H5N1 Pandemic Influenza Vaccine in Children [clinicaltrials:NCT00491985]Immunogenicity and Safety of an Intramuscular A/H5N1 Inactivated, Split Virion Pandemic Influenza Vaccine in Adults [clinicaltrials:NCT00545701]Immunogenicity of the Inactivated Split-Virion Influenza Vaccine in Renal Transplant Subjects [clinicaltrials:NCT00606359]Study of Different Formulations of an Intramuscular A/H5N1 Inactivated, Split Virion Influenza Adjuvanted Vaccine [clinicaltrials:NCT00664417]Study of Inactivated, Split-Virion Influenza Vaccine Administered by Intradermal Route Versus Vaxigrip® in Adults [clinicaltrials:NCT00703651]Immunogenicity and Safety of the Inactivated, Split-Virion Influenza Vaccine, Northern Hemisphere 2008-2009 Formulation [clinicaltrials:NCT00718146]clinicaltrials:NCT00755274clinicaltrials:NCT00772109clinicaltrials:NCT00775450Study of Immune Response in Adults and Elderly Subjects Vaccinated With Inactivated Influenza Vaccines [clinicaltrials:NCT00776438]Safety and Immunogenicity of an Intramuscular A/H5N1 Inactivated, Split Virion Pandemic Influenza Vaccine in Children [clinicaltrials:NCT00884182]Novel Influenza A/H1N1 Split- Virion Vaccine in Healthy Population Aged 3 Years and Older [clinicaltrials:NCT00975572]clinicaltrials:NCT01055990DNA-based Influenza Vaccine in the Elderly [clinicaltrials:NCT01587131]Safety of H1N1 Influenza Vaccination in Pregnant Women [clinicaltrials:NCT01842997]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
Orthomyxoviridae Infections [clinicaltrials_resource:9da3f383276de9a4153d3938b5fd99b5]
Bio2RDF identifier
9da3f383276de9a4153d3938b5fd99b5
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:9da3f383276de9a4153d3938b5fd99b5
identifier
clinicaltrials_resource:9da3f383276de9a4153d3938b5fd99b5
title
Orthomyxoviridae Infections
@en
label
Orthomyxoviridae Infections [clinicaltrials_resource:9da3f383276de9a4153d3938b5fd99b5]
@en
Orthomyxoviridae Infections